DRI Healthcare Trust (TSE:DHT.UN) Price Target Cut to C$17.50 by Analysts at National Bankshares

DRI Healthcare Trust (TSE:DHT.UN) had its target price decreased by equities researchers at National Bankshares from C$19.50 to C$17.50 in a report issued on Thursday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. National Bankshares’ target price would suggest a potential upside of 48.56% from the stock’s current price.

A number of other equities research analysts have also recently issued reports on DHT.UN. CIBC dropped their price target on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating on the stock in a research note on Thursday, December 12th. Raymond James dropped their price target on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of C$17.94.

DRI Healthcare Trust Price Performance

Shares of TSE DHT.UN traded down C$0.07 during midday trading on Thursday, reaching C$11.78. 19,006 shares of the stock were exchanged, compared to its average volume of 38,299. DRI Healthcare Trust has a twelve month low of C$10.39 and a twelve month high of C$17.43. The firm has a 50-day simple moving average of C$11.98 and a two-hundred day simple moving average of C$12.57.

About DRI Healthcare Trust

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.